A carregar...
Dysregulation of BET Proteins in Levodopa-Induced Dyskinesia
Levodopa (L-DOPA) remains the most effective pharmacological treatment for Parkinson’s Disease (PD) but its use is limited by the development of debilitating drug-related side effects, particularly L-DOPA induced dyskinesia (LID). LID is a consequence of long-term L-DOPA use, and in model systems is...
Na minha lista:
| Publicado no: | Neurobiol Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410664/ https://ncbi.nlm.nih.gov/pubmed/28286180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2017.03.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|